Argentina’s Roemmers group has acquired local drugmaker Elisium. Sources have told Pharmabiz that the group will pay close to US$ 20 million to buy the company from Gador and Casasco.
Roemmers, the largest pharmaceutical company in Argentina, continues to expand. Pharmabiz has exclusively learned that the group has bought Elisium from its peers Gador and Casasco.
According to reliable sources, the value of the acquisition has been set at around US$ 20 million.
The move shows the Roemmers group aiming to consolidate its portfolio of OTC medicines through its firm Gramon Millet, which will administer the newly acquired products.
The new brands acquired from Elisium include the antipyretic Mejoral; the sleep inducer Melatol; the analgesics Ibuprofeno Elisium and Ibumejoral; and the allergy remedy Alermuc. The products will fit in synergy with Roemmer’s existing OTC portfolio. See website
Highlights of the portfolio include the flu remedy Decidex Grip; the multivitamin 102 Plus; the eyewash Coltix; the oral anesthetic Oralsone; and the supplement Megacistin, though the star product is Sertal, an antispasmodic which, in its basic version, became available OTC in 2012. See article
Sources told Pharmabiz that Roemmers will also receive Elisium’s representation agreements for the dietary supplements Naturaloe, Nutrifarma and Calsa, boosting its firepower even more and moving into the health food shop channel for the first time.
The acquisition will make Argentina’s top drugmaker a strong player in OTC and gain it expertise in what is a very dynamic sector internationally, if not in Argentina, where OTC medicines account for only 20% of the total market for medicines.
